Strs Ohio Sells 12,491 Shares of Cooper Companies, Inc. (The) (COO)

Strs Ohio lowered its position in Cooper Companies, Inc. (The) (NYSE:COO) by 8.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 127,891 shares of the medical device company’s stock after selling 12,491 shares during the period. Strs Ohio owned 0.26% of Cooper Companies, Inc. (The) worth $30,324,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of COO. Advisory Services Network LLC lifted its position in shares of Cooper Companies, Inc. (The) by 30.6% in the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after purchasing an additional 107 shares during the period. YorkBridge Wealth Partners LLC lifted its position in shares of Cooper Companies, Inc. (The) by 2.1% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after acquiring an additional 11 shares during the period. Acrospire Investment Management LLC lifted its position in shares of Cooper Companies, Inc. (The) by 50.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after acquiring an additional 200 shares during the period. Visionary Asset Management Inc. acquired a new position in shares of Cooper Companies, Inc. (The) during the 2nd quarter valued at $201,000. Finally, Penserra Capital Management LLC lifted its position in shares of Cooper Companies, Inc. (The) by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock valued at $211,000 after acquiring an additional 102 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

A number of research analysts recently issued reports on the stock. Piper Jaffray Companies boosted their target price on shares of Cooper Companies, Inc. (The) to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. BidaskClub lowered shares of Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Jefferies Group LLC reiterated a “buy” rating and issued a $250.00 target price on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Stephens reiterated an “equal weight” rating and issued a $250.00 target price (up previously from $235.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Finally, Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $265.00 target price for the company in a research note on Tuesday, October 10th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $261.11.

Shares of Cooper Companies, Inc. (NYSE:COO) traded down $2.89 during midday trading on Friday, reaching $229.06. 341,800 shares of the company’s stock were exchanged, compared to its average volume of 428,798. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. Cooper Companies, Inc. has a twelve month low of $158.73 and a twelve month high of $256.39. The company has a market capitalization of $11,353.78, a PE ratio of 24.81, a P/E/G ratio of 1.99 and a beta of 0.55.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The firm had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same quarter last year, the business earned $2.30 earnings per share. The business’s revenue was up 8.0% on a year-over-year basis. sell-side analysts forecast that Cooper Companies, Inc. will post 9.72 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Strs Ohio Sells 12,491 Shares of Cooper Companies, Inc. (The) (COO)” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/11/11/strs-ohio-trims-stake-in-cooper-companies-inc-coo.html.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply